The global patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). Patient registry software is used to create and manage registries that collect and store patient data related to a specific medical condition. It is additionally used for clinical research, public health initiatives, quality improvement, and chronic disease management. Patient registries are instrumental in advancing research, treatment, and care for patients with specific health issues. The software can also be used to identify eligible participants, track their progress, analyze data, monitor and manage public health concerns, and monitor the quality of care provided to patients.
Browse the full report description of “Patient Registry Software Market Size, Share & Trends Analysis Report by Type of Registry (Disease-Specific Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-Alone Software, and Integrated Software), by Deployment (On-Premises, and Cloud), and by End-User (Hospitals and Health Systems, Government Organizations, and Third Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/patient-registry-software-market
Furthermore, it is used to manage chronic diseases and provide timely interventions to improve health outcomes. The market’s growth is attributed to disease-specific research. The increasing emphasis on understanding and treating specific diseases, such as NMOSD in the case of SPHERES, is driving the development of disease-specific registries, which in turn drives demand for patient registration software. For instance, in May 2023,CorEvitas, LLC, launched the SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD) Registry is now collecting biospecimens from consented participants. This essential endeavor promises to offer clinically annotated biospecimens to aid in the development of new diagnostic tests and therapy options for people suffering from Neuromyelitis Optica Spectrum Disorder (NMOSD).
Furthermore, government agencies and regulatory bodies may encourage the establishment of patient registries to advance public health and ensure the safety of treatments. in January 2022, San Diego-based healthcare company launched that it has partnered with the National Pancreas Foundation (NPF) to create the nation’s largest dynamic pancreatic patient disease database. The database has the potential to accelerate cutting-edge research faster than traditional approaches.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Component
o By Deployment
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Dacima Software, Inc., DSG, Inc., FIGmd Inc., Global Vision TechnologiesImage Trend Inc., LexisNexis group, IBM Corp., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Patient Registry Software Market Report Segment
By Type of Registry
By Type of Software
By Deployment
By End-User
Global Patient Registry Software Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/patient-registry-software-market